These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 18000882)

  • 1. Mass spectrometric determination of insulins and their degradation products in sports drug testing.
    Thevis M; Thomas A; Schänzer W
    Mass Spectrom Rev; 2008; 27(1):35-50. PubMed ID: 18000882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass spectrometry in sports drug testing: Structure characterization and analytical assays.
    Thevis M; Schänzer W
    Mass Spectrom Rev; 2007; 26(1):79-107. PubMed ID: 16888758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulins in equine urine: qualitative analysis by immunoaffinity purification and liquid chromatography/tandem mass spectrometry for doping control purposes in horse-racing.
    Kuuranne T; Thomas A; Leinonen A; Delahaut P; Bosseloir A; Schänzer W; Thevis M
    Rapid Commun Mass Spectrom; 2008; 22(3):355-62. PubMed ID: 18181226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doping control analysis of intact rapid-acting insulin analogues in human urine by liquid chromatography-tandem mass spectrometry.
    Thevis M; Thomas A; Delahaut P; Bosseloir A; Schänzer W
    Anal Chem; 2006 Mar; 78(6):1897-903. PubMed ID: 16536426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New drugs and methods of doping and manipulation.
    Thevis M; Kohler M; Schänzer W
    Drug Discov Today; 2008 Jan; 13(1-2):59-66. PubMed ID: 18190865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of human insulin-like growth factor-1 and qualitative detection of its analogues in plasma using liquid chromatography/electrospray ionisation tandem mass spectrometry.
    Bredehöft M; Schänzer W; Thevis M
    Rapid Commun Mass Spectrom; 2008; 22(4):477-85. PubMed ID: 18236437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass spectrometric identification of peptide hormones in doping-control analysis.
    Thevis M; Schänzer W
    Analyst; 2007 Apr; 132(4):287-91. PubMed ID: 17554406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass spectrometric identification of degradation products of insulin and its long-acting analogues in human urine for doping control purposes.
    Thomas A; Thevis M; Delahaut P; Bosseloir A; Schänzer W
    Anal Chem; 2007 Mar; 79(6):2518-24. PubMed ID: 17300174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometric identification and characterization of a new long-term metabolite of metandienone in human urine.
    Schänzer W; Geyer H; Fusshöller G; Halatcheva N; Kohler M; Parr MK; Guddat S; Thomas A; Thevis M
    Rapid Commun Mass Spectrom; 2006; 20(15):2252-8. PubMed ID: 16804957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of therapeutics with growth-hormone secretagogue activity in human urine for doping control purposes.
    Thevis M; Wilkens F; Geyer H; Schänzer W
    Rapid Commun Mass Spectrom; 2006; 20(22):3393-402. PubMed ID: 17051614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommended criteria for the mass spectrometric identification of target peptides and proteins (<8 kDa) in sports drug testing.
    Thevis M; Loo JA; Loo RR; Schänzer W
    Rapid Commun Mass Spectrom; 2007; 21(3):297-304. PubMed ID: 17200979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for 2-quinolinone-derived selective androgen receptor agonists in doping control analysis.
    Thevis M; Kohler M; Maurer J; Schlörer N; Kamber M; Schänzer W
    Rapid Commun Mass Spectrom; 2007; 21(21):3477-86. PubMed ID: 17985352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin.
    Thevis M; Thomas A; Schänzer W
    Handb Exp Pharmacol; 2010; (195):209-26. PubMed ID: 20020367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doping control analysis of selected peptide hormones using LC-MS(/MS).
    Thevis M; Thomas A; Schänzer W
    Forensic Sci Int; 2011 Dec; 213(1-3):35-41. PubMed ID: 21752560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteases in doping control analysis.
    Thevis M; Maurer J; Kohler M; Geyer H; Schänzer W
    Int J Sports Med; 2007 Jul; 28(7):545-9. PubMed ID: 17525883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qualitative determination of synthetic analogues of insulin in human plasma by immunoaffinity purification and liquid chromatography-tandem mass spectrometry for doping control purposes.
    Thevis M; Thomas A; Delahaut P; Bosseloir A; Schänzer W
    Anal Chem; 2005 Jun; 77(11):3579-85. PubMed ID: 15924392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doping control analysis of tricyclic tetrahydroquinoline-derived selective androgen receptor modulators using liquid chromatography/electrospray ionization tandem mass spectrometry.
    Thevis M; Kohler M; Thomas A; Schlörer N; Schänzer W
    Rapid Commun Mass Spectrom; 2008 Aug; 22(16):2471-8. PubMed ID: 18634123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 6alpha-Methylandrostenedione: gas chromatographic mass spectrometric detection in doping control.
    Parr MK; Kazlauskas R; Schlörer N; Opfermann G; Piper T; Schulze G; Schänzer W
    Rapid Commun Mass Spectrom; 2008; 22(3):321-9. PubMed ID: 18181236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator andarine (S-4) for routine doping control purposes.
    Thevis M; Thomas A; Fusshöller G; Beuck S; Geyer H; Schänzer W
    Rapid Commun Mass Spectrom; 2010 Aug; 24(15):2245-54. PubMed ID: 20623476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometric determination of gonadotrophin-releasing hormone (GnRH) in human urine for doping control purposes by means of LC-ESI-MS/MS.
    Thomas A; Geyer H; Kamber M; Schänzer W; Thevis M
    J Mass Spectrom; 2008 Jul; 43(7):908-15. PubMed ID: 18563864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.